Skip to content

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity – Ligand Pharmaceuticals (NASDAQ:LGND), Channel Therapeutics (AMEX:CHRO)

Ligand Pharmaceuticals Incorporated LGND and Channel Therapeutics Corporation CHRO on Thursday signed a definitive merger agreement to combine Ligand’s wholly owned subsidiaries, Pelthos Therapeutics Inc. and LNHC, Inc. (collectively Pelthos) with CHRO Merger Sub Inc.,… EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity – Ligand Pharmaceuticals (NASDAQ:LGND), Channel Therapeutics (AMEX:CHRO)